Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Investors Business Daily
Investors Business Daily
Business
INVESTOR'S BUSINESS DAILY

Stocks To Watch: CME Group Cl A Sees Relative Strength Rating Jump To 92

On Tuesday, CME Group Cl A received a positive adjustment to its Relative Strength (RS) Rating, from 88 to 92.

IBD's proprietary RS Rating measures market leadership by using a 1 (worst) to 99 (best) score that identifies how a stock's price performance over the trailing 52 weeks matches up against other publicly traded companies.

Over 100 years of market history shows that the market's biggest winners tend to have an 80 or better RS Rating in the early stages of their moves.

How To Use Stock Charts To Stay Profitable And Protected

CME Group Cl A is still inside a buy zone after moving past a 249.02 buy point in a cup without handle. Once a stock moves 5% or higher beyond the initial entry, it's considered extended and out of buy range.

The company showed 6% earnings growth last quarter. Sales increased 6%.

The company holds the No. 6 rank among its peers in the Financial Services-Specialty industry group. Tiptree, Tradeweb Markets and X Financial ADR are among the top 5 highly rated stocks within the group.

This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.

RELATED:

Stocks With Rising Relative Strength Ratings

Why Should You Use IBD's Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

Ready To Grow Your Investing Skills? Join An IBD Meetup Group!

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.